Real-time enrollment status for this age-related macular degeneration clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:05 AM UTC
| NCT Number | NCT05626114 |
| Recruiting Status | Recruiting |
| Condition | Age-related Macular Degeneration |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | July 15, 2026 (3 days ago) |
As of July 18, 2026: Clinical trial NCT05626114 is currently recruiting participants. This phase2 study for age-related macular degeneration is actively seeking new participants at 15 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05626114 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05626114 was last updated 3 days ago (July 15, 2026). HelloStudys verifies this status automatically.